CASI Pharmaceuticals Inc (NASDAQ:CASI)

6.85
Delayed Data
As of 4:00pm ET
 -0.04 / -0.58%
Today’s Change
0.91
Today|||52-Week Range
7.59
+110.77%
Year-to-Date
No recent news for CASI Pharmaceuticals Inc.

Today’s Trading

Previous close6.89
Today’s open7.00
Day’s range6.61 - 7.00
Volume790,803
Average volume (3 months)495,200
Market cap$215.4M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+22.73%
Earnings growth (this year)+29.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book9.59

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.21-2.18%
ATXIAvenue Therapeutics ...-0.05-1.11%
XENEXenon Pharmaceutical...-0.25-4.72%
APDNApplied DNA Sciences...+0.03+2.05%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 17, 2018
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts